Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-536-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity data is not available for the reaction mass. The reaction mass is considered to have a worst case LD50 of > 2000 mg/kg bw based on results of the constituents 19910-65-7 (SBP) and 105-64-6 (IPP).
IPP has an oral LD50 >5000mg/kg bw (similar to OECD 401, 1983). The LD50 for SBP is 4640 mg/kg bw (similar to OECD 401, 1967). Since IBP is structurally very similar to IPP and SBP the acute oral LD50 is expected to be in the same range, as a worst case 2000 mg/kg bw is assumed as the LD50 for the purpose of calculation the LD50 of the multi -constituent. The toxicity is low for these substances. The acute oral toxicity of the stabilizer is 515 mg/kg bw (similar to OECD 401, 1981).
100/ATEmix= 15/2000+ 6/5000 + 7/4640 + 72/515
ATEmix= 667 mg/kg bw
According to CLP rulesthe classification of the mixture would be Acute oral toxicity category 4, harmful.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1967
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- No CoA, pre-GLP, only males, limited information on animals and conditions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Remarks:
- performed pre-GLP
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Charles River CD
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: no data
- Females (if applicable) nulliparous and non-pregnant: not applicable
- Age at study initiation: no data
- Weight at study initiation: 151-186 grams
- Fasting period before study: yes
- Housing: metal cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
IN-LIFE DATES: From: To: no data - Route of administration:
- oral: gavage
- Vehicle:
- other: odorless mineral spirits
- Details on oral exposure:
- VEHICLE: odorless mineral spirits
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg
DOSAGE PREPARATION (if unusual):
D-225 was maintained at -18C (0 Fahrenheit) until administered, at which time these were permitted to warm to a temperature of 10C (50 Fahrenheit) prior to dosing. The equipment used to administer these compounds (syringes, needles, beakers and diluent) were chilled to 10C (50 Fahrenheit) prior to use. Immediately after administering these compounds they were destroyed in accordance with the sponsor's instructions. - Doses:
- 100, 215, 464, 1000, 2150, 4640 mg/kg
- No. of animals per sex per dose:
- 5 males
- Control animals:
- yes
- Remarks:
- vehicle controls
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: no data
- Necropsy of survivors performed: no
- Other examinations performed: none - Statistics:
- none
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- >= 4 640 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortalities occured
- Mortality:
- none
- Clinical signs:
- other: no data
- Gross pathology:
- no data
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LD50 > 4640 mg/kg bw, no mortalities
- Executive summary:
LD50 > 4640 mg/kg bw, no mortalities
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- June 23, 1983 to July 7, 1983
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Version / remarks:
- 1982
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- The test article, Diisopropyl Carbonate (Lot number 287-1942), was a clear, colorless liquid supplied by the Sponsor. Records concerning the test article purity, source, and other data required in 21 CFR, 58.135 are the responsibility of the Sponsor and are not presented in this report.
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc. (Portage, MI Facility), 251 Ballardvale Street, Wilmington, MA 10188
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Age at study initiation: no data, young
- Weight at study initiation: 175-215g
- Fasting period before study: overnight before dosing
- Housing: individually
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.8-24.4
- Humidity (%): 52-62
- Air changes (per hr): no data, well ventilated and airconditioned
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: June 23, 1983 to July 7, 1983 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 1.2ml
- Doses:
- 5 g/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: animals were obseverd for mortality and other clinical signs each hour on day 0 and twice daily for the remainder of the study. Animals were weighed on day 0, 7 and 14.
- Necropsy of survivors performed: yes - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortality observed
- Mortality:
- No mortality observed
- Clinical signs:
- other: Lethargy and ataxia were observed for all animals on the day of dosing and on the day following dosing for some animals. No stools were observed for 2 males and 4 females in the morning following dosing. Other abnormal clinical signs observed on the day o
- Gross pathology:
- Multiple stones in the urinary bladder and a moderately thickened urinary bladder were observed upon gross necropsy examination of one male. No other abnormalities were observed upon gross necropsy examinations of all animals, sacrificed on day 14.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LD50> 5000 mg/kg bw, no mortalities observed.
- Executive summary:
The test article, Diisopropyl Carbonate, was administered. by oral gavage to 5 male and 5 female albino rats at a dose level of 5 grams per kilogram of body weight to evaluate the acute oral toxic potential.. This study was designed to comply with procedures described in the EPA/OPP Guidelines, 1982. All animals survived the 14-day duration of the study and gained body weight. Lethargy and ataxia were observed for all animals on the day of dosing and. on the day following dosing for some animals. No stools were observed for 2 males and 4 females in the morning following dosing. Other abnormal clinical signs observed on the day of dosing included salivation (4 males), squinting (2 males), and crusty muzzle (2 males). No other abnormal clinical signs were observed during the study.
Multiple stones in the urinary bladder and a moderately thickened urinary bladder were observed upon gross necropsy examination of one male. No other abnormalities were observed upon gross necropsy examinations of all animals, sacrificed on day 14.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- WoE approach
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Remarks:
- comparable to guideline study with acceptable restrictions No CoA, pre-GLP, limited information on animals and conditions, only 2 animals used per each dose level, occlusive dressing, no necropsy, no data on individual animals.
- Adequacy of study:
- supporting study
- Study period:
- 1970
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- no
- Remarks:
- performed pre-GLP
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- The test materials were received from the Lucidol Division, Pennwalt Corporation, Buffalo, New York, on June 12, 1970. It was received as a clear liquid packed in dry ice.
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Source: no data
- Age at study initiation: no data
- Weight at study initiation: 1810 - 2450 grams
- Housing: individually in hanging metal cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
IN-LIFE DATES: From: To: no data - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: back
- % coverage: no data
- Type of wrap if used: occluded and wrapped with a gauze bandage
REMOVAL OF TEST SUBSTANCE
- Washing (if done): tepid tap water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 200 and 2000 mg/kg - Duration of exposure:
- 24 hours
- Doses:
- 200 and 2000 mg/kg
- No. of animals per sex per dose:
- 2
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Body weights were measured initially and at 7 and 14 days after compound application.
- Necropsy of survivors performed: no - Statistics:
- none
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All of the rabbits at each of the dosage levels tested survived the study period.
- Clinical signs:
- other: Twenty-four hours after application, erythema (very slight to moderate) and edema (slight to moderate) was observed at the site of application in each animal tested. Desquamation was noted during the 14 day observation period. Slight erythema remained in
- Gross pathology:
- Not applicable
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- None of the animals died at 2000 mg/kg bw, there were only 2 animals in each group. The study is not suitable for C&L purposes.
- Executive summary:
None of the animals died at 2000 mg/kg bw, there were only 2 animals in each group. The study is not suitable for C&L purposes.
Reference
Endpoint conclusion
- Quality of whole database:
- No valid study available.
Additional information
Justification for classification or non-classification
Acute oral toxicity data is not available for the reaction mass.The reaction mass is considered to have a worst case LD50 of > 2000 mg/kg bw based on results of the constituents 19910-65-7 (SBP) and 105-64-6 (IPP).
IPP has an oral LD50 >5000mg/kg bw (similar to OECD 401, 1983). The LD50 for SBP is 4640 mg/kg bw (similar to OECD 401, 1967). Since IBP is structurally very similar to IPP and SBP the acute oral LD50 is expected to be in the same range, as a worst case 2000 mg/kg bw is assumed as the LD50 for the purpose of calculation the LD50 of the multi -constituent. The toxicity is low for these substances. The acute oral toxicity of the stabilizer is 515 mg/kg bw (similar to OECD 401, 1981).
100/ATEmix= 15/2000+ 6/5000 + 7/4640 + 72/515
ATEmix= 667 mg/kg bw
According to CLP rulesthe classification of the mixture would be Acute oral toxicity category 4, harmful.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.